Jennifer A. Low

9.6k citations
74 papers · 7.2k indexed · 5 hit papers · h-index 30
Topics
Hedgehog Signaling Pathway Studies (24 papers)Cancer Treatment and Pharmacology (15 papers)Cancer-related Molecular Pathways (11 papers)

In The Last Decade

Jennifer A. Low

69 papers receiving 7.0k citations

Hit Papers

Efficacy and Safety of Vismodegib in Advanced Basal-Cell ...2009202620142020201220092009200920152505007501000

Peers

Jennifer A. Low
Comparison fields: 5 of 150
  • Molecular Biology 5.0k
  • Oncology 2.9k
  • Epidemiology 1.1k
  • Dermatology 1.0k
  • Cancer Research 961
Replace Raoul Tibes with:
Raoul Tibes United States
Stephen E. Gould United States
James C. Marsters United States
David Hogg Canada
Wendy J. Levin United States
Jordi Rodón United States
Amita Patnaik United States
Hans‐Peter Sinn Germany
Giovanni Tonon Italy
Christiane B. Knobbe‐Thomsen Germany
Jennifer A. Low relative to Raoul Tibes United States Raoul Tibes's profile →
Citations per field
00.5×
Raoul Tibes · 1×
Citations per year

Countries citing papers authored by Jennifer A. Low

Since Specialization
Citations

This map shows the geographic impact of Jennifer A. Low's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jennifer A. Low with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jennifer A. Low more than expected).

Fields of papers citing papers by Jennifer A. Low

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jennifer A. Low. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jennifer A. Low. The network helps show where Jennifer A. Low may publish in the future.

Co-authorship network of co-authors of Jennifer A. Low

This figure shows the co-authorship network connecting the top 25 collaborators of Jennifer A. Low. A scholar is included among the top collaborators of Jennifer A. Low based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jennifer A. Low. Jennifer A. Low is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2
An Oncogenic NTRK Fusion in a Patient with Soft-Tissue Sarcoma with Response to the Tropomyosin-Related Kinase Inhibitor LOXO-101breakdown →
302
3 143
4 49
5 9
6 17
7
Efficacy and Safety of Vismodegib in Advanced Basal-Cell Carcinomabreakdown →
1011
8 420
9 97
10 74
11 88
12
Smoothened Mutation Confers Resistance to a Hedgehog Pathway Inhibitor in Medulloblastomabreakdown →
670
13
Treatment of Medulloblastoma with Hedgehog Pathway Inhibitor GDC-0449breakdown →
761
14
A validated assay for gamma-H2AX as a pharmacodynamic biomarker of response to DNA damage
1
15 145
16 92
17 39
18 21
19 10
20 7

About Jennifer A. Low

Jennifer A. Low is a scholar working on Oncology, Pharmacy and Architecture, having authored 74 papers that have together received 7.2k indexed citations. Recurring topics across this work include Hedgehog Signaling Pathway Studies (24 papers), Cancer Treatment and Pharmacology (15 papers) and Cancer-related Molecular Pathways (11 papers). The work is most often cited by research in Dermatology (1.0k citations), Oncology (2.9k citations) and Molecular Biology (5.0k citations). Jennifer A. Low has collaborated with scholars based in United States, United Kingdom and Belgium. Frequent co-authors include Charles M. Rudin, Frédéric J. de Sauvage, Robert L. Yauch, Christine L. Hann, Patricia LoRusso, Daniel D. Von Hoff, Josina C. Reddy, Richard Graham, Howard Mackey and Kapila Ratnam. Their work appears in journals such as Science, New England Journal of Medicine and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026